Related references
Note: Only part of the references are listed.Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk The Cardiovascular Health Study
Rozenn N. Lemaitre et al.
CIRCULATION-HEART FAILURE (2019)
ST-segment elevation myocardial infarction with non-chest pain presentation at the Emergency Department: Insights from the Singapore Myocardial Infarction Registry
Jeremy Zhenwen Pong et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
CerS1-Derived C18:0 Ceramide in Skeletal Muscle Promotes Obesity-Induced Insulin Resistance
Sarah M. Turpin-Nolan et al.
CELL REPORTS (2019)
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach
Suryaprakash Raichur et al.
MOLECULAR METABOLISM (2019)
Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence
Wee Siong Chew et al.
JCI INSIGHT (2019)
Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations
Wee Siong Chew et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Cohort Profile: The Singapore Multi-Ethnic Cohort (MEC) study
Kristin Hui Xian Tan et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
Linda R. Peterson et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients
Mark M. Mitsnefes et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
The ceramide ratio: a predictor of cardiometabolic risk
Trevor S. Tippetts et al.
JOURNAL OF LIPID RESEARCH (2018)
Cardiovascular Implications of Sphingomyelin Presence in Biological Membranes
Petros Kikas et al.
EUROPEAN CARDIOLOGY REVIEW (2018)
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention
Piyushkumar A. Mundra et al.
JCI INSIGHT (2018)
Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease
Amin Polzin et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Sphingolipids and Lipoproteins in Health and Metabolic Disorders
Jahangir Iqbal et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial ( Prevencion con Dieta Mediterranea)
Dong D. Wang et al.
CIRCULATION (2017)
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
Reijo Laaksonen et al.
EUROPEAN HEART JOURNAL (2016)
Improved batch correction in untargeted MS-based metabolomics
Ron Wehrens et al.
METABOLOMICS (2016)
Large-scale untargeted LC-MS metabolomics data correction using between-batch feature alignment and cluster-based within-batch signal intensity drift correction
Carl Brunius et al.
METABOLOMICS (2016)
Discovering and validating between-subject variations in plasma lipids in healthy subjects
Husna Begum et al.
SCIENTIFIC REPORTS (2016)
Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice
Sumita Mishra et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The effect of altered sphingolipid acyl chain length on various disease models
Woo-Jae Park et al.
BIOLOGICAL CHEMISTRY (2015)
Sphingolipids in cardiovascular diseases and metabolic disorders
Sonia Borodzicz et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Trends in Stroke Incidence and 28-Day Case Fatality in a Nationwide Stroke Registry of a Multiethnic Asian Population
Chuen Seng Tan et al.
STROKE (2015)
Lipidomic Deep Profiling: An Enhanced Workflow to Reveal New Molecular Species of Signaling Lipids
Pradeep Narayanaswamy et al.
ANALYTICAL CHEMISTRY (2014)
Inhibition of Glycosphingolipid Synthesis Ameliorates Atherosclerosis and Arterial Stiffness in Apolipoprotein E-/- Mice and Rabbits Fed a High-Fat and -Cholesterol Diet
Subroto Chatterjee et al.
CIRCULATION (2014)
Human Plasma Lipidome Is Pleiotropically Associated With Cardiovascular Risk Factors and Death
Claire Bellis et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Lipidome of Atherosclerotic Plaques from Hypercholesterolemic Rabbits
Lazar A. Bojic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
Alexander Sigruener et al.
PLOS ONE (2014)
Biological functions of sphingomyelins
J. Peter Slotte
PROGRESS IN LIPID RESEARCH (2013)
The role of sphingolipids in selected cardiovascular diseases
Krzysztof Kurek et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2013)
Impact of Sphingomyelin Synthase 1 Deficiency on Sphingolipid Metabolism and Atherosclerosis in Mice
Zhiqiang Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Role of sulfatide in normal and pathological cells and tissues
Tadanobu Takahashi et al.
JOURNAL OF LIPID RESEARCH (2012)
Chain length-specific properties of ceramides
Sabine Groesch et al.
PROGRESS IN LIPID RESEARCH (2012)
Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice
Xiaogang Wang et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Platelets in atherosclerosis
Dirk Lievens et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Association of Plasma Sphingomyelin Levels and Incident Coronary Heart Disease Events in an Adult Population Multi-Ethnic Study of Atherosclerosis
Joseph Yeboah et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids
Delphine Milhas et al.
FEBS LETTERS (2010)
Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection
Katherine Sattler et al.
CARDIOVASCULAR RESEARCH (2009)
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology
Catherine Pavoine et al.
CARDIOVASCULAR RESEARCH (2009)
Macrophage Sphingomyelin Synthase 2 Deficiency Decreases Atherosclerosis in Mice
Jing Liu et al.
CIRCULATION RESEARCH (2009)
The SPTLC3 Subunit of Serine Palmitoyltransferase Generates Short Chain Sphingoid Bases
Thorsten Hornemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The sphingolipid salvage pathway in ceramide metabolism and signaling
Kazuyuki Kitatani et al.
CELLULAR SIGNALLING (2008)
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
Sekar Kathiresan et al.
NATURE GENETICS (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice
Jibin Dong et al.
JOURNAL OF LIPID RESEARCH (2006)
Plasma sphingomyelin and subclinical atherosclerosis: Findings from the multi-ethnic study of atherosclerosis
J Nelson et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors
T Kimura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism
K Hanada
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2003)
Role for sulfatides in platelet aggregation
M Merten et al.
CIRCULATION (2001)
Share Paper
